1.
Infection and Chemotherapy
;
: 572-577, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-890953
RESUMEN
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report four pediatric HCT recipients with d-ADV treated successfully with BCV.
2.
Infection and Chemotherapy
;
: 572-577, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-898657
RESUMEN
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report four pediatric HCT recipients with d-ADV treated successfully with BCV.